Tag: Avenue Therapeutics

Avenue Therapeutics Submits New Drug Application for IV Tramadol

The company submitted a new drug application to the US Food and Drug Administration for its treatment IV tramadol.

5 Top NASDAQ Pharma Stocks Year-to-Date

We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.

5 Top Weekly NASDAQ Biotech and Pharma Stocks: La Jolla Soars

INN looks at the top NASDAQ biotech and pharma stocks over the course of the week and what may have...

Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial

Avenue Therapeutics (NASDAQ:ATXI) a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today announced that...

5 Top Weekly NASDAQ Biotech Stocks: Cocrystal on Top

Cocrystal Pharma, Ra Pharmaceuticals, Avenue Therapeutics, Imprimis Pharmaceuticals and Nightstar Therapeutics were last week's top gainers on the NASDAQ Biotechnology...